---
document_datetime: 2023-09-21 21:06:05
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/imraldi-epar-all-authorised-presentations_en.pdf
document_name: imraldi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.2345168
conversion_datetime: 2025-12-31 05:01:49.956618
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/17/1216/001   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass)                   | 0.8 ml (40 mg/0.8 ml)                | 1 pre-filled syringe + 2 alcohol pads                               |
|--------------------|-----------|---------------|----------------------------------|----------------------|----------------------------------------------|--------------------------------------|---------------------------------------------------------------------|
| EU/1/17/1216/002   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass)                   | 0.8 ml (40 mg/0.8 ml)                | 2 pre-filled syringes + 2 alcohol pads                              |
| EU/1/17/1216/003   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass)                   | 0.8 ml (40 mg/0.8 ml)                | 4 pre-filled syringes + 4 alcohol pads                              |
| EU/1/17/1216/004   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass)                   | 0.8 ml (40 mg/0.8 ml)                | 6 pre-filled syringes + 6 alcohol pads                              |
| EU/1/17/1216/005   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass) in pre-filled pen | 0.8 ml (40 mg/0.8 ml)                | 1 pre-filled pen + 2 alcohol pads                                   |
| EU/1/17/1216/006   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass) in pre-filled pen | 0.8 ml (40 mg/0.8 ml)                | 2 pre-filled pens+2 alcohol pads                                    |
| EU/1/17/1216/007   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass) in pre-filled pen | 0.8 ml (40 mg/0.8 ml)                | 4 pre-filled pens+4 alcohol pads                                    |
| EU/1/17/1216/008   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass) in pre-filled pen | 0.8 ml (40 mg/0.8 ml)                | 6 pre-filled pens+6 alcohol pads                                    |
| EU/1/17/1216/009   | Imraldi   | 40 mg/ 0.8 ml | Solution for injection           | Subcutaneous use     | vial (glass)                                 | 0.8 ml (40 mg/0.8 ml)                | 2 x (1 vial + 1 syringe + 1 needle + 1 vial adapter+2 alcohol pads) |
| EU/1/17/1216/010   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass)                   | 0.4 ml (40 mg/0.4 ml)                | 1 pre-filled syringe + 2 alcohol pads                               |
| EU/1/17/1216/011   | Imraldi   | 40 mg         | Solution for                     | Subcutaneous         | pre-filled syringe                           | 0.4 ml                               | 2 pre-filled syringes                                               |
| EU/1/17/1216/012   | Imraldi   | 40 mg         | Solution for                     | Subcutaneous         | pre-filled syringe                           | 0.4 ml                               | 4 pre-filled syringes                                               |
| EU/1/17/1216/013   | Imraldi   | 40 mg         | injection Solution for injection | use Subcutaneous use | (glass) pre-filled syringe (glass)           | (40 mg/0.4 ml) 0.4 ml (40 mg/0.4 ml) | + 4 alcohol pads 6 pre-filled syringes + 6 alcohol pads             |
| EU/1/17/1216/014   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass) in pre-filled pen | 0.4 ml (40 mg/0.4 ml)                | 1 pre-filled pen + 2 alcohol pads                                   |
| EU/1/17/1216/015   | Imraldi   | 40 mg         | Solution for injection           | Subcutaneous use     | pre-filled syringe (glass) in pre-filled pen | 0.4 ml (40 mg/0.4 ml)                | 2 pre-filled pens+2 alcohol pads                                    |

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/17/1216/016   | Imraldi   | 40 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen   | 0.4 ml (40 mg/0.4 ml)   | 4 pre-filled pens+4 alcohol pads   |
|--------------------|-----------|---------|--------------------------|--------------------|------------------------------------------------|-------------------------|------------------------------------|
| EU/1/17/1216/017   | Imraldi   | 40 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen   | 0.4 ml (40 mg/0.4 ml)   | 6 pre-filled pens+6 alcohol pads   |